The capabilities of the life sciences practice at Creel, García-Cuéllar, Aiza y Enríquez, S.C. take in M&A transactions, the provision of regulatory advice on pharmaceutical, healthcare, medical device and consumer products matters. The team has noted experience in clinical trials, litigation before administrative authorities, and the manufacturing, packaging and export of pharmaceutical products. A recent highlight saw the team advise Daesang Corporation on including one of their products as a natural flavouring additive under the Mexican legal and regulatory applicable framework. Leadership is shared between Leonel Pereznieto, whose broad practice encompasses M&A, compliance and insurance law; and counsel Guillermo Govela, who draws on experience acting as general legal counsel for Mexico’s Federal Ministry of Health and specialises in regulatory law affecting healthcare and consumer products.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The firm's comprehensive office makes it very attractive. Its reputation and level of specialisation are unmatched. The team and extensive infrastructure greatly contribute to providing prompt and professional service.'
- ‘Thanks to the expertise of each lawyer and the large number of lawyers on each team, they are able to provide a fast, professional and responsive service.'
Key clients
- Daesang Corporation
- AstraZeneca
Work highlights
Assisted AstraZeneca with an administrative challenge for the inclusion of one of its pharmaceutical products in the National Compendium of Health Supplies issued by the General Health Council of Mexico.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Leonel Pereznieto; Guillermo Govela